Detalhe da pesquisa
1.
The use of Lutetium-177 PSMA radioligand therapy with high dose rate brachytherapy for locally recurrent prostate cancer after previous definitive radiation therapy: a randomized, single-institution, phase I/II study (ROADSTER).
BMC Cancer
; 23(1): 362, 2023 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37081426
2.
Patient-reported acute fatigue in elderly breast cancer patients treated with and without regional nodal radiation.
Breast Cancer Res Treat
; 183(2): 391-401, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32651754
3.
Immunotherapy and Radiation Therapy Sequencing in Breast Cancer: A Systematic Review.
Int J Radiat Oncol Biol Phys
; 118(5): 1422-1434, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38195030
4.
Rapid multi-catheter segmentation for magnetic resonance image-guided catheter-based interventions.
Med Phys
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713919
5.
Deep learning-based ultrasound auto-segmentation of the prostate with brachytherapy implanted needles.
Med Phys
; 51(4): 2665-2677, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37888789
6.
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19â¯Gy or two fractions of 13.5â¯Gy: A 9-year update.
Radiother Oncol
; : 110381, 2024 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38879130
7.
Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancer.
Brachytherapy
; 22(2): 188-194, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36549968
8.
Acute toxicity and health-related quality of life outcomes of localized prostate cancer patients treated with magnetic resonance imaging-guided high-dose-rate brachytherapy: A prospective phase II trial.
Brachytherapy
; 22(1): 58-65, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36414526
9.
Clinical Outcomes of Patients with Metastatic Breast Cancer Treated with Hypo-Fractionated Liver Radiotherapy.
Cancers (Basel)
; 15(10)2023 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345175
10.
A comparative study of patient-reported outcomes after contemporary radiation techniques for prostate cancer.
Radiother Oncol
; 171: 164-172, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35500786
11.
Health related quality of life outcomes following stereotactic body radiotherapy in patients with oligo-metastatic disease: A systematic review and individual patient data meta-analysis.
Radiother Oncol
; 173: 163-169, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35680076
12.
Gantry-Based 5-Fraction Elective Nodal Irradiation in Unfavorable-Risk Prostate Cancer: Outcomes From 2 Prospective Studies Comparing SABR Boost With MR Dose-Painted HDR Brachytherapy Boost.
Int J Radiat Oncol Biol Phys
; 112(3): 735-743, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637882
13.
The Impact of Disease Progression on Health-Related Quality of Life Outcomes in Patients With Oligometastatic Disease at 12 Months Post Stereotactic Body Radiation Therapy.
Int J Radiat Oncol Biol Phys
; 114(5): 989-999, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35907512
14.
Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer.
Front Oncol
; 12: 1084708, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36465337
15.
Salvage Low-Dose-Rate Prostate Brachytherapy: Clinical Outcomes of a Phase 2 Trial for Local Recurrence after External Beam Radiation Therapy (NRG Oncology/RTOG 0526).
Int J Radiat Oncol Biol Phys
; 112(5): 1115-1122, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34740768
16.
Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?
Radiother Oncol
; 169: 51-56, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35151715
17.
MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer.
Front Oncol
; 12: 971344, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36091157
18.
Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer.
Int J Radiat Oncol Biol Phys
; 114(4): 693-704, 2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36031465
19.
[Tolerance of adjuvant radiotherapy in the treatment of stage I seminoma]. / Tolérance de la radiothérapie dans le traitement adjuvant des séminomes testiculaires stade I.
J Med Liban
; 59(4): 202-5, 2011.
Artigo
em Francês
| MEDLINE | ID: mdl-22746008
20.
Acute and late side-effects after low dose-rate brachytherapy for prostate cancer; incidence, management and technical considerations.
Brachytherapy
; 20(5): 956-965, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33972182